Oocyte retrieval timing based on spontaneous luteinizing hormone surge during natural cycle in vitro fertilization treatment

In ncIVF treatment OR scheduling based on the occurrence of spontaneous LH surge yields acceptable oocyte recovery, fertilization, and embryo cleavage rates.

Like Comment


Daniel Bodri, M.D., M.Sc., Ph.D., Satoshi Kawachiya, M.D., Masae Kondo, M.Sc., Ryutaro Kato, M.Sc., Tsunekazu Matsumoto, M.D., Ph.D.

Volume 101, Issue 4, Pages 1001-1007.e2



To determine the efficiency of oocyte retrieval (OR) timing based on the occurrence of spontaneous LH surge during natural cycle IVF (ncIVF) treatment.


Retrospective cohort study. The cohort was divided into five subgroups according to the presumed stage of spontaneous LH surge on scheduling day (1A: before onset; 1B: surge start; 2: ascending slope; 3: peak; and 4: descending slope).


Private infertility clinic.


Three hundred sixty-five infertile patients who underwent 1,138 ncIVF treatment cycles during 2008–2011.


Drug-free ncIVF treatment.

Main Outcome Measure(s):

Rate of successfully retrieved, fertilized oocytes, cleaved embryos, and live births per scheduled oocyte retrieval.


In 61% of the cycles OR was scheduled before or just at the start of the LH surge (groups 1A–1B), whereas in the remaining cases it was scheduled after the surge had already started (groups 2–4). The proportion of cycles with successfully recovered (range, 71%–86%), inseminated (range, 61%–78%), fertilized oocytes (range, 47%–68%), cleaved embryos (range, 45%–66%), and live births (range, 4.1%–9.2%) was not significantly different among subgroups.


In ncIVF treatment OR timing based on the occurrence of spontaneous LH surge is feasible, yielding acceptable oocyte recovery, fertilization, and embryo cleavage rates. This strategy combined with a rapid and low-risk OR procedure permits the management of a large ncIVF program on a 7-days-per-week basis within working hours.

Read the full text at: http://www.fertstert.org/article/S0015-0282(14)00047-8/fulltext

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.